Involvement of Bax, Bcl-2 and caspase 3 in hydroxyurea- or etoposide-induced apoptosis of mouse interleukin-3-dependent lymphoma cells

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 999-1007

  Olmos, Gemma ^a   Prieto, Alfredo ^a   Herráez, Angel ^a   Tejedor, M Cristina ^a   Alvarez Mon, Melchor ^a   Diez, José C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Bax; Bcl 2; Caspase; Etoposide; Hydroxyurea; Interleukin; Lymphoma; P53

Indexed keywords

CASPASE 3; ETOPOSIDE; HYDROXYUREA; INTERLEUKIN 3; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG WITHDRAWAL; FLOW CYTOMETRY; FLUOROMETRY; IMMUNOBLOTTING; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CULTURE MEDIA; ENZYME INDUCTION; ETOPOSIDE; HYDROXYUREA; INTERLEUKIN-3; LYMPHOMA; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17444390862     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Collins MK, Marvel J, Malde P and Lopez-Rivas A: Interleukin-3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 76: 1043-1051, 1992.
2. Kaplinsky C, Lotem J and Sachs I: Protection of human myeloid leukemic cells against doxorrubicin-induced apoptosis by granulocyte macrophage colony stimulating factor and interleukin-3. Leukemia 10: 460-465, 1996.
3. Carroll MP, Clark-Lewis I, Rapp UR and May WS: Interleukin-3 and granulocyte-macrophage colony-stimulating factor mediate rapid phosphorylation and activation of cytosolic c-raf. J Biol Chem 265: 19812-19817, 1996.
4. Perkins GR, Marshall CJ and Collins MK: The role of MAP kinase kinase in interleukin-3 stimulation of proliferation. Blood 87: 3669-3675, 1996.
5. Songyang Z, Baltimore D, Cantley LC, Kaplan DR and Franke T: Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci USA 94: 11345-11350, 1997.
6. Ranjan P, Sodhi A and Srivastava A: Cisplatin and interferon-γ treated murine macrophages induce apoptosis in tumor cell lines. Anti-Cancer Drug 8: 797-806, 1997.
7. Von Knethen A, Lotero A and Brüne B: Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression. Oncogene 17: 387-394, 1998.
8. Kizaki H and Onishi Y: Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells. Adv Enzyme Regul 37: 403-423, 1997.
9. Wang HI, Mao Y, Zhou N, Hu T, Hsiedh TS and Liu LF: ATP-bound topoisomerase II as a target for antitumor drugs. J Biol Chem 276: 15990-15995, 2001.
10. Sebestyén A, Mihalik R, Peták I and Kopper L: Modulation of apoptosis signaling in etoposide-treated lymphoma cells. Anti-Cancer Res 17: 2609-2614, 1997.
11. Fukumi A, Horiguchi-Yamada J, Nakada S, Nagai M, Ohno T and Yamada H: Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells. Mol Cell Biochem 206: 43-50, 2000.
12. Hendricks SP and Mathews CK: Allosteric regulation of vaccinia virus ribonucleotide reductase, analyzed by simultaneous monitoring of its four activities. J Biol Chem 273: 29519-29523, 1998.
13. Donehower RC: An overview of the clinical experience with hydroxyurea. Semin Oncol 19: 11-19, 1992.
14. Huyghe P, Dassonneville L, Fenaux P and Bailly C: Hydroxyurea-induced apoptosis in an EBV-immortalized lymphoblastoid cel line. Oncol Res 14: 235-245, 2004.
15. Yarbro JW: Mechanism of action of hydroxyurea. Semin Oncol 19: 1-10, 1992.
16. Johnston JB, Daeninck P, Verburg L, Lee K, Williams G, Israels LG, Mowat MR and Begleiter A: P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Leuk Lymphoma 26: 435-449, 1997.
17. McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ and Lowe SW: Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 94: 2345-2349, 1997.
18. Simonian PL, Grillot AM and Núñez G: Bcl-2 and Bcl-XL can differentially block chemotherapy-induce cell death. Blood 90: 1208-1216, 1997.
19. Fritzsche C, Zeller G, Knaup KX and Roemer K: No anti-apoptotic effects of single copies of mutant p53 genes in drug-treated tumor cells. Anti-Cancer Drugs 15: 679-688, 2004.
20. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S and Kalyanaran B: Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H2O2- and p53-dependent pathways. J Biol Chem 279: 25535-25543, 2004.
21. Messmer UK and Brüne B: Attenuation of p53 expression and Bax down-regulation during phorbol ester mediated inhibition of apoptosis. Br J Pharmacol 121: 625-634, 1997.
22. Lowe S, Bodis S, McClatchey A, Remington L, Riley HE, Fisher DE, Housman DE and Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-10, 1994.
23. Newcomb EW: P53 gene mutations in lympoid diseases and their possible relevance to drug resistance. Leuk Lymphoma 17: 211-221, 1995.
24. Newton K and Strasser A: Cell death control in lymphocytes. J Exp Med 191: 195-200, 2000.
25. Palacios C, Gutierrez del Arroyo A, Silva A and Collins MK: The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs. Oncogene 19: 3556-3559, 2000.
26. Gottlieb E, Haffner R, von Ruden T, Wagner EF and Oren M: Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J 13: 1368-1374, 1994.
27. Gottlieb E, Lindner S and Oren M: Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells. Cell Growth Diff 7: 301-310, 1996.
28. Gottlieb E and Oren M: p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J 17: 3587-3596, 1998.
29. Ding HF, McGill G, Rowan S, Schmaltz C, Shimamura A and Fisher DE: Oncogene dependent regulation of caspase activation by p53 protein in a cell-free system. J Biol Chem 273: 28378-28383, 1998.
30. Miyashita T and Reed JC: Tumor supressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
31. Kelekar A and Thompson CB: Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol 8: 324-330, 1998.
32. Maurer M, Tsai M, Metz M, Fish S, Korsmeyer SJ and Galli SJ: A role for Bax in the regulation of apoptosis in mouse mast cells. J Invest Dermatol 114: 1205-1206, 2000.
33. Low W, Olmos-Centenera G, Madsen C, Leverrier Y, Collins MK: Role of Bax in apoptosis of IL-3-dependent cells. Oncogene 20: 4476-4483, 2000.
34. Hockenbery D, Nuñez G, Milliman C, Schreiber RD and Korsmeyer S: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348: 334-336, 1990.
35. Zamzami N, Brenner C, Marzo I, Susin S and Kroemer G: Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16: 2265-2282, 1998.
36. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
37. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
38. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
39. Prieto A, Reyes E, Díaz D, Hernández-Fuentes MP, Monserrat, J, Perucha E, Munoz L, Vangioni R, de la Hera A, Orfao A and Álvarez-Mon M: A new method for the simultaneous analysis of growth and death of immunophenotypically defined cells in culture. Cytometry 39: 56-66, 2000.
40. Lowry OH, Rosenbrough AL, Farr AL and Randall LJ: Protein mesurement with the folin phenol reagent. J Biol Chem 193: 256-275, 1951.
41. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
42. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
43. Nicholson DW and Thornberry NA: Caspases: killer proteases. Trends Biochem Sci 22: 299-306, 1979.
44. Shen S-Ch, Ko ChH, Tseng S-W, Tsai S-H and Chen Y-Ch: Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production. Toxicol Appl Pharm 197: 84-95, 2004.
45. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-851, 1993.
46. Gross A, Jockel J, Wei MC and Korsmeyer SJ: Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17: 3878-3875, 1998.